Latest Period
Q4 2025
Security Snapshot
Profound Medical Corp. - Common Shares (PROF) Institutional Ownership
CUSIP: 74319B502
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
62
Shares (Excl. Options)
15,238,347
Price
$7.87
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Shares
- Symbol
- PROF on Nasdaq
- Shares outstanding
- 29,881,634
- Price per share
- $5.95
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 15,238,347
- Total reported value
- $119,864,543
- % of total 13F portfolios
- 0%
- Share change
- +3,983,324
- Value change
- +$31,389,798
- Number of holders
- 62
- Price from insider filings
- $5.95
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PROF - Profound Medical Corp. - Common Shares is tracked under CUSIP 74319B502.
- 62 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 62 to 10 between Q4 2025 and Q1 2026.
- Reported value moved from $119,864,543 to $24,891,261.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 62 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74319B502?
CUSIP 74319B502 identifies PROF - Profound Medical Corp. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74319B502:
Significant Owners of Profound Medical Corp. - Common Shares (PROF) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GAGNON SECURITIES LLC | 11% | $15,796,627 | 3,346,743 | Neil Gagnon | 31 Dec 2024 |
As of 31 Dec 2025, 62 institutional investors reported holding 15,238,347 shares of Profound Medical Corp. - Common Shares (PROF). This represents 51% of the company’s total 29,881,634 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Profound Medical Corp. - Common Shares (PROF) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FIL Ltd | 7.4% | 2,200,000 | +17% | 0.01% | $17,269,747 |
| GAGNON SECURITIES LLC | 6.5% | 1,944,061 | +12% | 3.1% | $15,299,760 |
| Rosalind Advisors, Inc. | 3.6% | 1,068,955 | +54% | 3.2% | $8,412,676 |
| ROYCE & ASSOCIATES LP | 3.3% | 990,348 | +15% | 0.08% | $7,770,973 |
| Timelo Investment Management Inc. | 3.3% | 979,967 | +62% | 8.2% | $7,712,340 |
| LETKO, BROSSEAU & ASSOCIATES INC | 3.2% | 970,675 | -1.6% | 0.12% | $7,627,447 |
| Gagnon Advisors, LLC | 3.2% | 962,186 | +7.3% | 4.8% | $7,572,404 |
| Alyeska Investment Group, L.P. | 2.3% | 678,570 | 0.02% | $5,340,346 | |
| MMCAP International Inc. SPC | 1.8% | 531,362 | +6.1% | 0.42% | $4,181,819 |
| ROYAL BANK OF CANADA | 1.6% | 473,218 | -2.6% | 0% | $3,725,000 |
| Ring Mountain Capital, LLC | 1.5% | 454,080 | +15% | 1.9% | $3,733,000 |
| ARDSLEY ADVISORY PARTNERS LP | 1.5% | 450,000 | +36% | 0.45% | $3,541,500 |
| First Eagle Investment Management, LLC | 1% | 312,707 | +7.3% | 0% | $2,461,004 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1% | 309,604 | 0.37% | $2,436,583 | |
| DAFNA Capital Management LLC | 0.96% | 285,710 | 0.52% | $2,248,538 | |
| Velan Capital Investment Management LP | 0.96% | 285,710 | 1.3% | $2,248,538 | |
| Bleichroeder LP | 0.85% | 254,753 | +39% | 0.35% | $2,004,906 |
| THOMPSON DAVIS & CO., INC. | 0.73% | 216,735 | +3.8% | 1% | $1,705,704 |
| FORMULA GROWTH LTD | 0.68% | 202,918 | 0% | 0.62% | $1,596,965 |
| NATIONAL BANK OF CANADA /FI/ | 0.63% | 189,510 | +9.6% | 0% | $1,421,905 |
| Empery Asset Management, LP | 0.48% | 143,532 | 0% | 1% | $1,129,597 |
| RAYMOND JAMES FINANCIAL INC | 0.45% | 135,285 | -11% | 0% | $1,064,693 |
| Zweig-DiMenna Associates LLC | 0.44% | 130,000 | 0.07% | $1,023,100 | |
| PERKINS CAPITAL MANAGEMENT INC | 0.38% | 114,280 | 0.71% | $899,384 | |
| Connective Capital Management, LLC | 0.33% | 100,000 | 0.46% | $787,000 |
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,841,238 | $24,891,261 | +$246,054 | $6.48 | 10 |
| 2025 Q4 | 15,238,347 | $119,864,543 | +$31,389,798 | $7.87 | 62 |
| 2025 Q3 | 11,063,194 | $54,283,775 | -$7,406,922 | $4.89 | 43 |
| 2025 Q2 | 12,482,340 | $73,650,616 | -$2,042,016 | $5.90 | 44 |
| 2025 Q1 | 12,825,851 | $73,303,109 | -$7,205,786 | $5.82 | 48 |
| 2024 Q4 | 13,763,555 | $102,960,287 | +$30,141,003 | $7.51 | 51 |
| 2024 Q3 | 9,406,781 | $74,869,184 | -$1,117,706 | $7.96 | 42 |
| 2024 Q2 | 9,510,240 | $80,047,787 | -$132,453 | $8.39 | 37 |
| 2024 Q1 | 9,500,142 | $80,114,995 | +$2,238,848 | $8.53 | 39 |
| 2023 Q4 | 9,251,176 | $77,759,535 | +$10,244,275 | $8.49 | 45 |
| 2023 Q3 | 7,489,374 | $75,450,155 | -$1,487,679 | $10.20 | 30 |
| 2023 Q2 | 7,634,234 | $98,724,050 | -$1,129,044 | $13.01 | 29 |
| 2023 Q1 | 7,726,121 | $71,704,219 | -$6,964,776 | $9.29 | 30 |
| 2022 Q4 | 8,472,949 | $91,726,796 | +$3,083,523 | $10.89 | 33 |
| 2022 Q3 | 8,745,198 | $35,381,959 | -$177,655 | $4.04 | 30 |
| 2022 Q2 | 8,675,590 | $63,032,248 | -$3,670,846 | $7.29 | 34 |
| 2022 Q1 | 9,402,835 | $84,635,691 | -$3,611,432 | $9.00 | 41 |
| 2021 Q4 | 9,774,988 | $109,777,858 | -$2,915,423 | $11.24 | 44 |
| 2021 Q3 | 8,722,358 | $127,589,352 | -$1,309,423 | $14.64 | 46 |
| 2021 Q2 | 8,722,951 | $142,593,346 | -$126,994 | $16.36 | 46 |
| 2021 Q1 | 8,673,835 | $174,440,609 | +$8,178,699 | $20.14 | 52 |
| 2020 Q4 | 8,182,487 | $168,377,436 | +$26,332,305 | $20.56 | 53 |
| 2020 Q3 | 7,009,150 | $123,510,789 | +$42,298,243 | $17.64 | 44 |
| 2020 Q2 | 4,612,581 | $78,146,000 | -$131,017 | $16.94 | 33 |
| 2020 Q1 | 4,764,927 | $46,182,000 | +$27,289,444 | $9.74 | 31 |
| 2019 Q4 | 1,948,600 | $21,824,000 | +$21,824,000 | $10.98 | 16 |